The Anticancer Fund announces the appointment of Alice Dossche as member of the board

Metzolimos metronomic cyclophosphamide (CP) and methotrexate (MTX) combined with zoledronic acid (ZA) and sirolimus (SIR) in patients with advanced solid tumor with bone metastasis and advanced pretreated osteosarcoma (OSS): A phase Ib study.

Results presented at the ASCO 2022 Annual Meeting in Chicago

Affordable life-saving drugs are missed by cancer treatment guidelines

First patient for trial with promising repurposed drug in pancreatic cancer

'Entrepreneurs with a heart': stand up to cancer!

A publication by scientists of the Anticancer Fund

Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population - A substudy of the VidME trial

Julie De Smedt, Sofie Van Kelst, Laudine Janssen, Vivien Marasigan, Veerle Boecxstaens, Marguerite Stas, Dirk Vanderschueren, Ipek Guler, Kris Bogaerts, Katleen Vandenberghe, Olivier Bechter, Jaak Billen, Arjen Nikkels, Tine Strobbe, Gabriella Emri, Diether Lambrechts, Marjan Garmyn. Acta Derm Venereol 2022; 102: adv00692. DOI: 10.2340/actadv.v102.262

The Anticancer Fund announces the appointment of new board members

3 Belgian cancer organisations join forces